Lauren A. Vanderlinden

Lauren A. Vanderlinden

Auto-generated profile, based on publicly available information

Lauren A. Vanderlinden

Division of Rheumatology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2020 in Pediatric Allergy and Immunology
Verified
Journal Article
Closed access
PDF file
CVCarina Venter
Carina Venter
Carlo AgostoniCarlo Agostoni
Carlo Agostoni
SASyed Hasan Arshad
Syed Hasan Arshad
MBMiriam Ben-Abdallah
Miriam Ben-Abdallah
GTGeorge Du Toit
George Du Toit
LOLiam O’Mahony
Liam O’Mahony

8 September 2021 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
LVLauren A. Vanderlinden
Lauren A. Vanderlinden
RJRandi Johnson
Randi Johnson
PCPatrick Carry
Patrick Carry
FDFran Dong
Fran Dong
DDDawn L. DeMeo
Dawn L. DeMeo
KKKaterina Kechris
Katerina Kechris
Objective: Illumina BeadChip arrays are commonly used to generate DNA methylation data for large epidemiological studies. Updates in technology over time create challenges for data harmonization within and between studies, many of which obtained data from the older 450K and newer EPIC platforms. The pre-processing pipeline for DNA methylation is not trivial, and influences the downstream analyses. Incorporating different platforms adds a new level of technical variability that has not yet been taken into account by recommended pipelines. Our study evaluated the performance of various tools on different versions of platform data harmonization at each step of pre-processing pipeline, including quality control (QC), normalization, batch effect adjustment, and genomic inflation. We illustrate our novel approach using 450K and EPIC data from the Diabetes Autoimmunity Study in the Young (DAISY) prospective cohort.Results: We found normalization and probe filtering had the biggest effect on data harmonization. Employing a meta-analysis was an effective and easily executable method for accounting for platform variability. Correcting for genomic inflation also helped with harmonization. We present guidelines for studies seeking to harmonize data from the 450K and EPIC platforms, which includes the use of technical replicates for evaluating numerous pre-processing steps, and employing a meta-analysis.

30 July 2021 in Genes
Verified
Journal Article
Open access
PDF file
PCPatrick Carry
Patrick Carry
ETElizabeth Terhune
Elizabeth Terhune
GTGeorge D. Trahan
George D. Trahan
LVLauren A. Vanderlinden
Lauren A. Vanderlinden
CWCambria I. Wethey
Cambria I. Wethey
NMNancy Hadley Miller
Nancy Hadley Miller
Epigenetic mechanisms may contribute to idiopathic scoliosis (IS). We identified 8 monozygotic twin pairs with IS, 6 discordant (Cobb angle difference > 10°) and 2 concordant (Cobb angle difference ≤ 2°). Genome-wide methylation in blood was measured with the Infinium HumanMethylation EPIC Beadchip. We tested for differences in methylation and methylation variability between discordant twins and tested the association between methylation and curve severity in all twins. Differentially methylated region (DMR) analyses identified gene promoter regions. Methylation at cg12959265 (chr. 7 DPY19L1) was less variable in cases (false discovery rate (FDR) = 0.0791). We identified four probes (false discovery rate, FDR < 0.10); cg02477677 (chr. 17, RARA gene), cg12922161 (chr. 2 LOC150622 gene), cg08826461 (chr. 2), and cg16382077 (chr. 7) associated with curve severity. We identified 57 DMRs where hyper- or hypo-methylation was consistent across the region and 28 DMRs with a consistent association with curve severity. Among DMRs, 21 were correlated with bone methylation. Prioritization of regions based on methylation concordance in bone identified promoter regions for WNT10A (WNT signaling), NPY (regulator of bone and energy homeostasis), and others predicted to be relevant for bone formation/remodeling. These regions may aid in understanding the complex interplay between genetics, environment, and IS.

1 March 2020 in Epilepsy Research
Verified
Journal Article
Closed access
HOHeather O'LEary
Heather O'LEary
LVLauren Vanderlinden
Lauren Vanderlinden
LSLara Southard
Lara Southard
ACAnna Castano
Anna Castano
LSLaura Saba
Laura Saba
TBTim Benke
Tim Benke

13 November 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
EWElizabeth Walker-Short
Elizabeth Walker-Short
TBTeresa Buckner
Teresa Buckner
TVTim Vigers
Tim Vigers
PCPatrick Carry
Patrick Carry
LVLauren A. Vanderlinden
Lauren A. Vanderlinden
JNJill M. Norris
Jill M. Norris
We assessed associations between infant diet (e.g., breastfeeding and introduction to solid foods) and DNA methylation in infancy and childhood. We measured DNA methylation in peripheral blood collected in infancy (9–15 months of age) in 243 children; and in a subset of 50 children, we also measured methylation in childhood (6–9 years of age) to examine persistence, and at birth (in cord blood) to examine temporality. We performed multivariable linear regression of infant diet on the outcome of methylation using epigenome-wide and candidate site approaches. We identified six novel CpG sites associated with breastfeeding duration using an EWAS approach. One differentially methylated site presented directionally consistent associations with breastfeeding (cg00574958, CPT1A) in infancy and childhood but not at birth. Two differentially methylated sites in infancy (cg19693031, TXNIP; cg23307264, KHSRP) were associated with breastfeeding and were not present at birth; however, these associations did not persist into childhood. Associations between infant diet and methylation in infancy at three sites (cg22369607, AP001525.1; cg2409200, TBCD; cg27173510, PGBD5) were also present at birth, suggesting the influence of exposures other than infant diet. Infant diet exposures are associated with persistent methylation differences in CPT1A, which may be one mechanism behind infant diet’s long-term health effects.

25 July 2025 in Diabetes Care
Verified
Journal Article
Closed access
LVLauren A. Vanderlinden
Lauren A. Vanderlinden
EWEllen Wong
Ellen Wong
RJRandi K. Johnson
Randi K. Johnson
PCPatrick Carry
Patrick Carry
FDFran Dong
Fran Dong
JNJill M. Norris
Jill M. Norris
OBJECTIVE: Multiple studies have reported an inverse association between self-reported smoking during pregnancy and offspring type 1 diabetes (T1D) risk. We investigated the association between DNA methylation (DNAm) smoke exposure scores, parental self-reported smoking, and islet autoimmunity (IA) and T1D risk in children at high risk of T1D. RESEARCH DESIGN AND METHODS: We used longitudinal data from the Diabetes Autoimmunity Study in the Young cohort, including 205 IA case and 206 control participants (87 and 88 were T1D case and control participants, respectively), matched by age, race/ethnicity, and sample availability. DNAm profiles were obtained from cord or peripheral blood using the Infinium Human Methylation 450K or EPIC BeadChip. Three published DNAm smoking scores were calculated at every time point. To estimate in utero smoke exposure, participant-specific intercepts were derived from mixed-effects models of longitudinal DNAm scores. These intercepts strongly correlated with cord blood scores (r = 0.85–0.95; n = 179), indicating their utility as proxies for in utero smoke exposure. Associations with IA/T1D were evaluated using logistic regression, adjusting for HLA-DR3/4, first-degree relative status, and sex. RESULTS: Multivariable models showed both maternally reported smoking during pregnancy and higher DNAm smoking scores to be associated with lower risk of IA and T1D. Maternal smoking showed a strong inverse association with IA (odds ratio [OR] 0.24; 95% CI 0.10–0.54). Rauschert and McCartney DNAm scores showed consistent inverse associations with both outcomes (OR 0.65–0.83 for SD increase). CONCLUSIONS: Our study supports existing literature indicating in utero smoke exposure is associated with reduced IA and T1D risk. Further research is essential to uncover the underlying mechanisms.